C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
12/2006
12/13/2006	CN1878751A Urea derivative and process for producing the same
12/13/2006	CN1876664A Organometallic complex and organic electroluminescent device using the same
12/13/2006	CN1876633A Method for preparing high optical purity pitavastatin calcium raw material drug
12/13/2006	CN1876610A Novel aromatic compound and organic electroluminescnet element containing the same
12/13/2006	CN1289485C Preparation of an anhydrous quinoline-based EETP inhibitor by crystallization
12/13/2006	CN1289484C Process for Producing Aliprazo
12/13/2006	CN1289483C Heterocyclic derivatives of glycinamide and its pharmaceutical uses
12/13/2006	CN1289469C Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors
12/13/2006	CN1289468C Naphthol derivative and charge control agent comprising the same
12/13/2006	CN1289087C Quinoline derivatives as neuropeptide y antagonists
12/13/2006	CN1289086C Uses for anti-malarial therapeutic agents
12/12/2006	US7148259 hydroxyamidines; antibiotic resistance
12/12/2006	US7148239 Method of enhancing cellular production of molecular chaperon, hydroxylamine derivatives useful for enhancing the chaperon production and the preparation thereof
12/12/2006	US7148237 Nitrogen-containing heteroaryl compounds having HIV integrase inhibitory activity
12/12/2006	US7148221 Vanilloid receptor ligands and their use in treatments
12/12/2006	US7148198 Antibacterial agents
12/12/2006	US7148069 Method for analysis of compounds with amino group and analytical reagent therefor
12/07/2006	WO2006130080A2 Quinoline derivatives as nk3 anatgonists
12/07/2006	WO2006129134A1 Synergic combinations comprising a styrylquinoline compound and other hiv infection therapeutic agents
12/07/2006	WO2006128802A2 3-methanesulfonylquinolines as gaba-b enhancers
12/07/2006	WO2006044362A3 N-sulfonylpiperidine cannabinoid receptor 1 antagonists
12/07/2006	US20060276676 Non-symmetrical gelling agent
12/07/2006	US20060276653 Process for producing quinoline compound
12/07/2006	US20060276518 Aryl and heteroaryl compounds and methods to modulate coagulation
12/07/2006	US20060276505 Acylhydrazine P2X7 antagonists and uses thereof
12/07/2006	US20060276493 Sulfur compounds such as phenylmethyl [2R-hydroxy-3-[(3-methylbutyl) (phenylsulfonyl)amino]-1S-(phenylmethyl)propyl]carbamate, used for prevention of viral diseases and replication
12/07/2006	US20060276487 New compounds useful for DPP-IV enzyme inhibition
12/07/2006	US20060276476 such as vascular cell adhesion molecules and fibronectins, administered for the treatment of asthma, multiple sclerosis or inflammatory bowel diseases in mammals; (3S)-3-{[({1-[(2-chlorophenyl)methyl]-4-hydroxy-2-oxo-1,2-dihydro-3quinolinyl}amino)carbonyl]amino}-3-(4-methylphenyl)propanoic acid
12/07/2006	US20060276467 Sodium channel modulators
12/07/2006	US20060276409 N-Hydroxy-N-(1-(2-carbamoylalkylaminocarbonyl)ethyl)formamides: [(Formyl-hydroxy-amino)-methyl]-3-cyclopentyl-propionic acid (1-dimethyl-carbamoyl-2,2-dimethyl-propyl)-amide; bacterial polypeptide deformylase inhibitors
12/07/2006	DE10394213B4 Verfahren zur Synthses von Bis(4-substituierten Chinolyl)disulfiden A process for Synthses of bis (4-substituted-quinolyl) disulphides
12/07/2006	CA2611060A1 Quinoline derivatives as nk3 antagonists
12/07/2006	CA2610456A1 3-methanesulfonylquinolines as gaba-b enhancers
12/07/2006	CA2610029A1 Synergic combinations comprising a quinoline compound and other hiv infection therapeutic agents
12/06/2006	EP1727813A1 2-propanol and 2-propylamine derivatives and their use as glucocorticoid ligands
12/06/2006	EP1727802A1 Substituted quinoline compounds for use as selective estrogen receptor modulator
12/06/2006	CN1874776A 4-anilino-3-quinolinecarbonitriles for the treatment of chronic myelogenous leukemia (CML)
12/06/2006	CN1288137C 7-heterocyclyl quinoline and thieno[2,3,-b] pyridine derivatives useful as antagonists of gonadotropin releasing hormone
12/06/2006	CN1288136C Process for producing optically active oxoheptenoic acid ester
12/05/2006	US7145014 Process for the preparation of quinoline derivatives
12/05/2006	US7145013 N-[4-[[4-(5-chloro-2-hydroxyphenyl)-1,2-dihydro-2-oxo-6-(trifluoromethyl)-3-quinolinyl]thio]phenyl]ethanesulfonamide for example; potassium channel modulators for treating erectile dysfunction and irritable bowel syndrome
12/05/2006	US7145011 Reacting aniline compound and glyoxylic acid and olefin in solvent; applying microwave radiation
12/05/2006	US7144993 Process for the preparation of 4-methyl-7-aminoquinolones
12/05/2006	US7144896 heterocyclic imines such as 3-[6-(1-Methanesulfonyl-1-methyl-ethyl)-quinolin-8-yl]-N-[6-(4-methylsulfanyl-phenyl)-pyridin-3-yl]-benzamide, used as phosphodiesterases (pde4) inhibitors; side effect reduction
12/05/2006	US7144893 4-aryl quinols and analogs thereof as therapeutic agents
12/05/2006	US7144888 Vanilloid receptor ligands and their use in treatments
12/05/2006	US7144883 Substituted fused ring sulfonamides containing, e.g., naphthalene, isoquinoline, quinoline, benzofuran or benzothiophene rings; treatment of conditions relating to obesity, type II diabetes and CNS disorders
11/2006
11/30/2006	WO2006127945A1 Compositions and methods of treating retinal disease
11/30/2006	WO2006127207A1 Methods of synthesizing substituted 3-cyanoquinolines and intermediates thereof
11/30/2006	WO2006127205A2 Methods of preparing 3-cyano-quinolines and intermediates made thereby
11/30/2006	WO2006127203A2 Methods of synthesizing 6-alkylaminoquinoline derivatives
11/30/2006	WO2006126939A1 Novel 8-sulfonylamino-3 aminosubstituted chroman or tetrahydronaphtalene derivatives modulating the 5ht6 receptor
11/30/2006	WO2006126938A1 Novel 8-sulfonyl-3 aminosubstituted chroman or tetrahydronaphtalene derivatives modulating the 5ht6 receptor
11/30/2006	WO2006125769A1 Process for preparing (alpha s, beta r)-6-bromo-alpha-[2-(dimethylamino)ethyl]-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinolineethanol
11/30/2006	WO2006099301A3 Apoptosis inhibitors
11/30/2006	US20060270693 Ether derivative
11/30/2006	US20060270683 Polymorphs of aripiprazole
11/30/2006	US20060270670 Methods of synthesizing 6-alkylaminoquinoline derivatives
11/30/2006	US20060270669 Method of preparing 3-cyano-quinolines and intermediates made thereby
11/30/2006	US20060270651 Antibacterial agents
11/30/2006	CA2609747A1 Novel 8-sulfonylamino-3 aminosubstituted chroman or tetrahydronaphthalene derivatives modulating the 5ht6 receptor
11/30/2006	CA2609735A1 Novel 8-sulfonyl-3 aminosubstituted chroman or tetrahydronaphthalene derivatives modulating the 5ht6 receptor
11/30/2006	CA2609659A1 Azanaphthalenes, compositions and methods for treating retinal disease
11/30/2006	CA2609186A1 Methods of synthesizing substituted 3-cyanoquinolines and intermediates thereof
11/30/2006	CA2608589A1 Methods of synthesizing 6-alkylaminoquinoline derivatives
11/30/2006	CA2608394A1 Methods of preparing 3-cyano-quinolines and intermediates made thereby
11/30/2006	CA2606675A1 Process for preparing (alpha s, beta r)-6-bromo-alpha-[2-(dimethylamino)ethyl]-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinolineethanol
11/29/2006	EP1726580A1 Aminophenylpropanoic acid derivative
11/29/2006	EP1725529A1 Bis bicyclic amides as vanilloid receptor ligands and their use in treatments of inflammatory and neuropatic pain
11/29/2006	EP1725524A1 Substituted heteroaryl- and phenylsulfamoyl compounds
11/29/2006	EP1725236A1 Novel m3 muscarinic acetylcholine receptor antagonists
11/29/2006	EP1503987B1 Preparation of an anhydrous quinoline-based cetp inhibitor by crystallization
11/29/2006	EP1114028B1 Aza-bicycles which modulate the inhibition of cell adhesion
11/29/2006	EP1032559B1 Aminoalkylphenol derivatives for treating depression and memory dysfunction
11/29/2006	CN1871007A Process for making sterile aripiprazole of desired mean particle size
11/29/2006	CN1286815C Novel 4-anilinoquinoline-3-carboxamides compound
11/29/2006	CN1286801C Dielectric substance with block effect preventing copper diffusion
11/28/2006	US7141609 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
11/28/2006	CA2379640C Certain alkylene diamine-substituted heterocycles
11/23/2006	WO2006122788A1 DERIVATIVES OF 4-(2-AMINO-1-HYDROXYETHYL)PHENOL AS AGONISTS OF THE β2 ADRENERGIC RECEPTOR
11/23/2006	WO2006061372A3 Phenylpiperazines with a combination of affinity for dopamine -d2 receptors and serotonin reuptake sites
11/23/2006	US20060264673 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
11/23/2006	US20060264630 Antidiabetic agents; modulate insulin drug resistance
11/23/2006	US20060264483 Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
11/23/2006	US20060264460 3-Cyanoquinoline inhibitors of Tpl2 kinase and methods of making and using the same
11/23/2006	US20060264435 Novel compounds
11/23/2006	US20060264434 Chemokine receptor binding heterocyclic compounds
11/23/2006	CA2608540A1 3-cyanoquinoline inhibitors of tpl2 kinase and methods of making and using the same
11/23/2006	CA2608493A1 Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the .beta.2 adrenergic receptor
11/22/2006	EP1724268A1 Compound having tgf-beta inhibitory activity and pharmaceutical composition containing same
11/22/2006	EP1724261A1 Photocharge separation using supramolecular complex of pi-electron type extended viologen derivative and porphyrin
11/22/2006	EP1723116A2 Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors
11/22/2006	EP1554243B1 Bicyclic benzamide compounds as histamine h3 receptor ligand useful in the treatment of neurological diseases
11/22/2006	EP1497291B1 Quinoline and aza-indole derivatives and their use as 5-ht6 ligands
11/22/2006	EP1343765B1 Quinolines and nitrogenated derivatives thereof substituted in 4-position by a piperazine-containing moiety and their use as antibacterial agents
11/22/2006	EP1268412B1 Sulphonamido-substituted bridged bicycloalkyl derivatives
11/22/2006	CN1867555A Rearranged pentanols, a process for their production and their use as anti-inflammatory agents
11/22/2006	CN1867552A Probe for disease with amyloid deposit, amyloid-staining agent, remedy and preventive for disease with amyloid deposit and diagnostic probe and staining agent for neurofibril change
11/22/2006	CN1867334A Quinolinone derivatives as inhibitors of c-fms kinase
11/22/2006	CN1285578C Substituted benzoic acid amides and use for inhibition of angiogenesis thereof

1 ... 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 ... 277